BOSTON BIOMEDICAL, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 15147
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 11244
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0030,021 NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENTJul 11, 17Feb 01, 18[A61K, C07D]
2018/0030,022 NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORSJul 20, 17Feb 01, 18[A61K, C07D]
2017/0319,537 NOVEL METHODS FOR TARGETING CANCER STEM CELLSJul 05, 17Nov 09, 17[A61K]
2017/0015,677 NEW TRICYCLIC QUINONE DERIVATIVEMar 30, 15Jan 19, 17[C07D]
2016/0075,697 HETEROCYCLIC SUBSTITUTED-3-HETEROARYLIDENYL-2-INDOLINONE DERIVATIVENov 24, 15Mar 17, 16[C07D]
2016/0030,384 2-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCERApr 09, 14Feb 04, 16[A61K]
2016/0031,888 3-(ARYL OR HETEROARYL) METHYLENEINDOLIN-2-ONE DERIVATIVES AS INHIBITORS OF CANCER STEM CELL PATHWAY KINASES FOR THE TREATMENT OF CANCERMar 13, 14Feb 04, 16[C07D]
2011/0111,496 BACTERIA-MEDIATED GENE MODULATION VIA microRNA MACHINERYJun 30, 08May 12, 11[C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9834532 Stat3 pathway inhibitors and cancer stem cell inhibitorsSep 29, 14Dec 05, 17[A61K, C07D]
9795595 Methods for treating cancerJan 26, 15Oct 24, 17[A61K, G01N]
9745278 Group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitorsSep 10, 08Aug 29, 17[A61K, C07D]
9730909 Methods for targeting cancer stem cellsMar 21, 11Aug 15, 17[A61K, A61P]
9732055 Compositions and methods for cancer treatmentSep 10, 08Aug 15, 17[A61K, C07D]
9725444 Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinasesJul 29, 14Aug 08, 17[A61K, C07D]
9381184 Compounds and compositions for targeting cancer stem cellsMar 10, 15Jul 05, 16[A61K, C07D]
9227962 Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeMar 13, 14Jan 05, 16[C07D]
9187454 Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereofMar 13, 14Nov 17, 15[C07D]
9084766 Compounds and compositions for targeting cancer stem cellsMar 21, 11Jul 21, 15[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0016,001 ASYMMETRIC INTERFERING RNA COMPOSITIONS THAT SILENCE K-RAS AND METHODS OF USES THEREOFAbandonedMar 16, 15Jan 19, 17[C12Q, C12N, G01N]
2012/0321,622 Compositions of Kinase Inhibitors and Their Use for Treatment of Cancer and Other Diseases Related to KinasesAbandonedAug 27, 12Dec 20, 12[A61K, C12N, C07D, A61P]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.